• SynteractHCR Full-Service CRO Brochure

    SynteractHCR is a multinational clinical research organization, formed from the merger of Synteract with Harrison Clinical Research in 2013, which provides global, full-service clinical trial services. We have more than two decades of experience supporting biopharma companies in all phases of clinical development across multiple therapeutic areas. We customize programs that will deliver timely, high quality data to help you get to decision points faster, taking time and cost out of drug development.

  • Is Your Biobank Ready For The Challenge Of Biomarker-Based Research?

    In this whitepaper we review the key drivers impacting “traditional” biobanking and detail the challenges such biobanks face in delivering new biomarker-based research. To facilitate the discussion of approaches to overcoming these challenges, we introduce the concept of Next Generation Biobanking and define the attributes an “ideal” Next Generation Biobank would need to drive effective biomarker-based research. Finally we demonstrate the benefits of adopting a Next Generation Biobanking approach, with a case study in cancer biomarker discovery. By Mark A Collins Ph.D., BioFortis, Inc.

  • Phase II Primary Insomnia Program In Need Of Full-Service CRO Management

    Clinilabs, a contract research organization (CRO), was selected by an international drug discovery and development company to provide full-service CRO management of a phase II primary insomnia program.

  • ePro Product Suite PHT Corporation was founded in 1994 out of a desire to enable more personalized clinical research. At the time, scientific researchers relying on paper diaries needed a proven way to capture reliable data from patients between clinic visits. PHT patented the model of using handheld devices in conjunction with online technologies in order to send subject self-assessments directly to a central server. These data could then be reviewed in real time for improved subject symptom, compliance, enrollment and safety monitoring. This PHT nvention has become the foundation for the modern electronic patient reported outcome (ePRO) industry.
  • Integrating Trial Data Processes Across Functional Areas Using Electronic Data Capture (EDC) Technology

    One common theme in the pharmaceutical, biotechnology and medical device industry is the constant pressure to accelerate development of drugs, biologics and products to market. By Bill Gluck, PhD, DATATRAK, and Lorraine D. Ellis, MS, MBA, Research Dynamics Consulting Group, Ltd.

  • Clinical Temporary Staffing SGS’ Life Science Services, part of the SGS group (55,000 employees) has 30 years of experience as a global contract service organization, providing integrated solutions from preclinical activities to Phase I-IV trials, bioanalytical and QC testing.
More White Papers & Case Studies


Biostatistical Services Biostatistical Services

Delivering high-quality and accurate data analysis, SynteractHCR is a contract research organization that provides robust and customized biostatistical services tailored to your study’s needs. At SynteractHCR, we believe that a statistician is a vital component in the clinical development process. Working as your partner, SynteractHCR’s expert biostatisticians will review your study’s needs and determine the best methods for collecting, analyzing and presenting your data, all in compliance with regulatory guidelines. Our team is trained to provide creative thinking and analysis optimized for your unique study designs. We provide access to your data in a format well-suited to your project requirements.

Outsourcing Clinical Trials Outsourcing Clinical Trials
SGS delivers temporary staffing for Clinical Trial Services to the Pharmaceutical Industry on National and International level that meets actual project needs with regard to outsourcing of clinical trial specialists.
Late Phase Clinical Biostatistics Late Phase Clinical Biostatistics
SGS’s mission in biostatistics is to offer clinical and statistical expertise from the design of the study protocol, to the data collection tools and all the way up to reviewing the clinical research report.
Late Phase Late Phase
Once a drug candidate is ready to move into later phase clinical trials, the potential for success increases but so do the costs, recruitment hurdles, and logistical challenges.
Biostatistics Biostatistics
SGS’s mission in biostatistics is to offer clinical and statistical expertise from the design of the study protocol, to the data collection tools and all the way up to reviewing the clinical research report.
Biostatistics Biostatistics
Involvement of Biostatistical Analysis at the start of clinical trial development is a key component in increasing the quality of the study design and the resulting data.
More Services & Products


More News